{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T01:22:14Z","timestamp":1744161734373},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1-2","license":[{"start":{"date-parts":[[2008,8,6]],"date-time":"2008-08-06T00:00:00Z","timestamp":1217980800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mol Cell Biochem"],"published-print":{"date-parts":[[2008,12]]},"DOI":"10.1007\/s11010-008-9892-4","type":"journal-article","created":{"date-parts":[[2008,8,5]],"date-time":"2008-08-05T03:07:58Z","timestamp":1217905678000},"page":"189-201","source":"Crossref","is-referenced-by-count":9,"title":["Genomic and proteomic characterization of YDOV-157, a newly established human epithelial ovarian cancer cell line"],"prefix":"10.1007","volume":"319","author":[{"given":"HanByoul","family":"Cho","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eun Suk","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soon Won","family":"Hong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Youn Jin","family":"Oh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sun Mi","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sang Wun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sung Hoon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Young Tae","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyoung Sun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang Kyu","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jae-Hoon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,8,6]]},"reference":[{"key":"9892_CR1","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3322\/canjclin.57.1.43","volume":"57","author":"A Jemal","year":"2007","unstructured":"Jemal A, Siegel R, Ward E et al (2007) Cancer statistics, 2007. CA Cancer J Clin 57:43\u201366","journal-title":"CA Cancer J Clin"},{"key":"9892_CR2","doi-asserted-by":"crossref","first-page":"6","DOI":"10.3322\/canjclin.48.1.6","volume":"48","author":"SH Landis","year":"1998","unstructured":"Landis SH, Murray T, Bolden S et al (1998) Cancer statistics, 1998. CA Cancer J Clin 48:6\u201329. doi: 10.3322\/canjclin.48.1.6","journal-title":"CA Cancer J Clin"},{"key":"9892_CR3","first-page":"5119","volume":"52","author":"CH Mok","year":"1992","unstructured":"Mok CH, Tsao SW, Knapp RC et al (1992) Unifocal origin of advanced human epithelial ovarian cancers. Cancer Res 52:5119\u20135122","journal-title":"Cancer Res"},{"key":"9892_CR4","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1006\/gyno.1993.1002","volume":"48","author":"SW Tsao","year":"1993","unstructured":"Tsao SW, Mok CH, Knapp RC et al (1993) Molecular genetic evidence of a unifocal origin for human serous ovarian carcinomas. Gynecol Oncol 48:5\u201310. doi: 10.1006\/gyno.1993.1002","journal-title":"Gynecol Oncol"},{"key":"9892_CR5","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1038\/bjc.1995.510","volume":"72","author":"EC Abeln","year":"1995","unstructured":"Abeln EC, Kuipers-Dijkshoorn NJ, Berns EM et al (1995) Molecular genetic evidence for unifocal origin of advanced epithelial ovarian cancer and for minor clonal divergence. Br J Cancer 72:1330\u20131336","journal-title":"Br J Cancer"},{"key":"9892_CR6","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1002\/(SICI)1097-0142(19980315)82:6<1197::AID-CNCR26>3.0.CO;2-0","volume":"82","author":"PA Wingo","year":"1998","unstructured":"Wingo PA, Ries LA, Rosenberg HM et al (1998) Cancer incidence and mortality, 1973\u20131995: a report card for the US. Cancer 82:1197\u20131207. doi :10.1002\/(SICI)1097-0142(19980315)82:6<1197::AID-CNCR26>3.0.CO;2-0","journal-title":"Cancer"},{"key":"9892_CR7","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.mce.2005.03.019","volume":"239","author":"K Garson","year":"2005","unstructured":"Garson K, Shaw TJ, Clark KV et al (2005) Models of ovarian cancer-are we there yet? Mol Cell Endocrinol 239:15\u201326. doi: 10.1016\/j.mce.2005.03.019","journal-title":"Mol Cell Endocrinol"},{"key":"9892_CR8","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1007\/BF01269885","volume":"123","author":"JW Kim","year":"1997","unstructured":"Kim JW, Lee CG, Lyu MS et al (1997) A new cell line from human undifferentiated carcinoma of the ovary: establishment and characterization. J Cancer Res Clin Oncol 123:82\u201390. doi: 10.1007\/BF01269885","journal-title":"J Cancer Res Clin Oncol"},{"key":"9892_CR9","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1006\/gyno.1997.4785","volume":"66","author":"Y Yuan","year":"1997","unstructured":"Yuan Y, Kim WH, Han HS et al (1997) Establishment and characterization of human ovarian carcinoma cell lines. Gynecol Oncol 66:378\u2013387. doi: 10.1006\/gyno.1997.4785","journal-title":"Gynecol Oncol"},{"key":"9892_CR10","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1002\/(SICI)1097-0215(19970926)73:1<143::AID-IJC22>3.0.CO;2-G","volume":"73","author":"V Ramakrishna","year":"1997","unstructured":"Ramakrishna V, Negri DR, Brusic V et al (1997) Generation and phenotypic characterization of new human ovarian cancer cell lines with the identification of antigens potentially recognizable by HLA-restricted cytotoxic T cells. Int J Cancer 73:143\u2013150. doi :10.1002\/(SICI)1097-0215(19970926)73:1<143::AID-IJC22>3.0.CO;2-G","journal-title":"Int J Cancer"},{"key":"9892_CR11","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1111\/j.1525-1438.2005.00148.x","volume":"15","author":"HF Guo","year":"2005","unstructured":"Guo HF, Feng J, Liu G et al (2005) Establishment and characterization of a human ovarian sarcomatoid carcinoma cell line BUPH:OVSC. Int J Gynecol Cancer 15:856\u2013865. doi: 10.1111\/j.1525-1438.2005.00148.x","journal-title":"Int J Gynecol Cancer"},{"key":"9892_CR12","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.bcmd.2005.06.008","volume":"35","author":"H Navabi","year":"2005","unstructured":"Navabi H, Croston D, Hobot J et al (2005) Preparation of human ovarian cancer ascites-derived exosomes for a clinical trial. Blood Cells Mol Dis 35:149\u2013152. doi: 10.1016\/j.bcmd.2005.06.008","journal-title":"Blood Cells Mol Dis"},{"key":"9892_CR13","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1016\/j.ejca.2006.01.057","volume":"42","author":"S Indraccolo","year":"2006","unstructured":"Indraccolo S, Tisato V, Agata S et al (2006) Establishment and characterization of xenografts and cancer cell cultures derived from BRCA1 \u2212\/\u2212 epithelial ovarian cancers. Eur J Cancer 42:1475\u20131483. doi: 10.1016\/j.ejca.2006.01.057","journal-title":"Eur J Cancer"},{"key":"9892_CR14","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s00262-007-0347-7","volume":"57","author":"TM Carr","year":"2008","unstructured":"Carr TM, Adair SJ, Fink MJ et al (2008) Immunological profiling of a panel of human ovarian cancer cell lines. Cancer Immunol Immunother 57:31\u201342. doi: 10.1007\/s00262-007-0347-7","journal-title":"Cancer Immunol Immunother"},{"key":"9892_CR15","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s11010-005-7556-1","volume":"275","author":"JP Gagne","year":"2005","unstructured":"Gagne JP, Gagne P, Hunter JM et al (2005) Proteome profiling of human epithelial ovarian cancer cell line TOV-112D. Mol Cell Biochem 275:25\u201355. doi: 10.1007\/s11010-005-7556-1","journal-title":"Mol Cell Biochem"},{"key":"9892_CR16","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/ng1294-399","volume":"8","author":"LS Friedman","year":"1994","unstructured":"Friedman LS, Ostermeyer EA, Szabo CI et al (1994) Confirmation of BRCA1 by analysis of germline mutations linked to breast and ovarian cancer in ten families. Nat Genet 8:399\u2013404. doi: 10.1038\/ng1294-399","journal-title":"Nat Genet"},{"key":"9892_CR17","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1006\/geno.1999.6026","volume":"62","author":"T Wagner","year":"1999","unstructured":"Wagner T, Stoppa-Lyonnet D, Fleischmann E et al (1999) Denaturing high-performance liquid chromatography detects reliably BRCA1 and BRCA2 mutations. Genomics 62:369\u2013376. doi: 10.1006\/geno.1999.6026","journal-title":"Genomics"},{"key":"9892_CR18","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1002\/1098-1004(200010)16:4<345::AID-HUMU7>3.0.CO;2-#","volume":"16","author":"E Gross","year":"2000","unstructured":"Gross E, Arnold N, Pfeifer K et al (2000) Identification of specific BRCA1 and BRCA2 variants by DHPLC. Hum Mutat 16:345\u2013353. doi :10.1002\/1098-1004(200010)16:4<345::AID-HUMU7>3.0.CO;2-#","journal-title":"Hum Mutat"},{"key":"9892_CR19","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1002\/cncr.22601","volume":"109","author":"YW Moon","year":"2007","unstructured":"Moon YW, Choi SH, Kim YT et al (2007) Adenosine triphosphate-based chemotherapy response assay (ATP-CRA)-guided platinum-based 2-drug chemotherapy for unresectable nonsmall-cell lung cancer. Cancer 109:1829\u20131835. doi: 10.1002\/cncr.22601","journal-title":"Cancer"},{"key":"9892_CR20","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1021\/ac950914h","volume":"68","author":"A Shevchenko","year":"1996","unstructured":"Shevchenko A, Wilm M, Vorm O et al (1996) Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels. Anal Chem 68:850\u2013858. doi: 10.1021\/ac950914h","journal-title":"Anal Chem"},{"key":"9892_CR21","first-page":"131","volume":"12","author":"K Yamada","year":"1999","unstructured":"Yamada K, Tachibana T, Hashimoto H et al (1999) Establishment and characterization of cell lines derived from serous adenocarcinoma (JHOS-2) and clear cell adenocarcinoma (JHOC-5, JHOC-6) of human ovary. Hum Cell 12:131\u2013138","journal-title":"Hum Cell"},{"key":"9892_CR22","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1006\/gyno.1996.0194","volume":"62","author":"A Alama","year":"1996","unstructured":"Alama A, Barbieri F, Favre A et al (1996) Establishment and characterization of three new cell lines derived from the ascites of human ovarian carcinomas. Gynecol Oncol 62:82\u201388. doi: 10.1006\/gyno.1996.0194","journal-title":"Gynecol Oncol"},{"key":"9892_CR23","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1002\/ijc.2910390216","volume":"39","author":"BT Hill","year":"1987","unstructured":"Hill BT, Whelan RD, Gibby EM et al (1987) Establishment and characterisation of three new human ovarian carcinoma cell lines and initial evaluation of their potential in experimental chemotherapy studies. Int J Cancer 39:219\u2013225. doi: 10.1002\/ijc.2910390216","journal-title":"Int J Cancer"},{"key":"9892_CR24","first-page":"6166","volume":"48","author":"SP Langdon","year":"1988","unstructured":"Langdon SP, Lawrie SS, Hay FG et al (1988) Characterization and properties of nine human ovarian adenocarcinoma cell lines. Cancer Res 48:6166\u20136172","journal-title":"Cancer Res"},{"key":"9892_CR25","first-page":"129","volume":"9","author":"V Dolo","year":"1997","unstructured":"Dolo V, Ginestra A, Violini S et al (1997) Ultrastructural and phenotypic characterization of CABA I, a new human ovarian cancer cell line. Oncol Res 9:129\u2013138","journal-title":"Oncol Res"},{"key":"9892_CR26","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1006\/gyno.1993.1034","volume":"48","author":"C Fuchtner","year":"1993","unstructured":"Fuchtner C, Emma DA, Manetta A et al (1993) Characterization of a human ovarian carcinoma cell line: UCI 101. Gynecol Oncol 48:203\u2013209. doi: 10.1006\/gyno.1993.1034","journal-title":"Gynecol Oncol"},{"key":"9892_CR27","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.ygyno.2006.07.023","volume":"104","author":"DR Scoles","year":"2007","unstructured":"Scoles DR, Pavelka J, Cass I et al (2007) Characterization of CSOC 882, a novel immortalized ovarian cancer cell line expressing EGFR, HER2, and activated AKT. Gynecol Oncol 104:120\u2013128. doi: 10.1016\/j.ygyno.2006.07.023","journal-title":"Gynecol Oncol"},{"key":"9892_CR28","first-page":"2979","volume":"51","author":"JR Marks","year":"1991","unstructured":"Marks JR, Davidoff AM, Kerns BJ et al (1991) Overexpression and mutation of p53 in epithelial ovarian cancer. Cancer Res 51:2979\u20132984","journal-title":"Cancer Res"},{"key":"9892_CR29","first-page":"5171","volume":"51","author":"A Okamoto","year":"1991","unstructured":"Okamoto A, Sameshima Y, Yokoyama S et al (1991) Frequent allelic losses and mutations of the p53 gene in human ovarian cancer. Cancer Res 51:5171\u20135176","journal-title":"Cancer Res"},{"key":"9892_CR30","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/S0140-6736(94)91578-4","volume":"343","author":"D Ford","year":"1994","unstructured":"Ford D, Easton DF, Bishop DT et al (1994) Risks of cancer in BRCA1-mutation carriers. Breast Cancer Linkage Consortium. Lancet 343:692\u2013695. doi: 10.1016\/S0140-6736(94)91578-4","journal-title":"Lancet"},{"key":"9892_CR31","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1002\/cncr.11310","volume":"97","author":"I Cass","year":"2003","unstructured":"Cass I, Baldwin RL, Varkey T et al (2003) Improved survival in women with BRCA-associated ovarian carcinoma. Cancer 97:2187\u20132195. doi: 10.1002\/cncr.11310","journal-title":"Cancer"}],"container-title":["Molecular and Cellular Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-008-9892-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11010-008-9892-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-008-9892-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,31]],"date-time":"2019-05-31T22:11:25Z","timestamp":1559340685000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11010-008-9892-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,8,6]]},"references-count":31,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2008,12]]}},"alternative-id":["9892"],"URL":"https:\/\/doi.org\/10.1007\/s11010-008-9892-4","relation":{},"ISSN":["0300-8177","1573-4919"],"issn-type":[{"value":"0300-8177","type":"print"},{"value":"1573-4919","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,8,6]]}}}